Masahide Yamamoto Selected Research

Multiple Myeloma

12/2019	Comparison between autologous and allogeneic stem cell transplantation as salvage therapy for multiple myeloma relapsing/progressing after autologous stem cell transplantation.
1/2019	Efficacy and Safety of a Weekly Cyclophosphamide-Bortezomib-Dexamethasone Regimen as Induction Therapy Prior to Autologous Stem Cell Transplantation in Japanese Patients with Newly Diagnosed Multiple Myeloma: A Phase 2 Multicenter Trial.
6/2016	A multicenter clinical study to determine the feasible initial dose of lenalidomide for maintenance therapy in patients with multiple myeloma following autologous peripheral blood stem-cell transplantation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Masahide Yamamoto Research Topics

Disease

6	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 04/2022 - 02/2012
6	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2022 - 03/2005
5	Neoplasms (Cancer) 04/2022 - 02/2004
5	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 07/2017 - 03/2005
3	Lymphoma (Lymphomas) 04/2022 - 04/2019
3	Infections 01/2020 - 09/2004
3	Multiple Myeloma 12/2019 - 06/2016
3	Leukemia 01/2015 - 07/2004
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 04/2022 - 04/2019
2	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 09/2019 - 01/2019
2	Chromosome Aberrations (Chromosome Abnormalities) 07/2017 - 03/2005
2	Disease Progression 06/2016 - 01/2016
2	Hemorrhage 01/2015 - 04/2006
2	Philadelphia Chromosome 05/2009 - 03/2005
1	Exanthema (Rash) 01/2022
1	Lobular Carcinoma 01/2022
1	Back Pain (Backache) 01/2022
1	Neoplasm Metastasis (Metastasis) 01/2022
1	Nasopharyngitis 01/2022
1	Pneumoperitoneum 01/2022
1	Breast Neoplasms (Breast Cancer) 01/2022
1	Epstein-Barr Virus Infections 01/2022
1	Carcinoma (Carcinomatosis) 01/2022
1	Cholelithiasis 01/2022
1	Headache (Headaches) 01/2022
1	Cytokine Release Syndrome 11/2021
1	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 06/2021
1	Dysgeusia (Parageusia) 01/2020
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2020
1	Pancytopenia 01/2020
1	Thrombocytopenia (Thrombopenia) 01/2020
1	Chronic Renal Insufficiency 01/2020
1	Hodgkin Disease (Hodgkin's Disease) 09/2019
1	Rare Diseases (Rare Disease) 09/2019
1	Opportunistic Infections (Opportunistic Infection) 01/2019
1	Bronchiolitis Obliterans 01/2019
1	Bronchiolitis 01/2019
1	Pemphigus (Pemphigus Vulgaris) 01/2019
1	GATA2 Deficiency 07/2017
1	Rheumatoid Arthritis 07/2017
1	Multi-centric Castleman's Disease 10/2016
1	Heart Failure 10/2016
1	Cardiomyopathies (Cardiomyopathy) 10/2016
1	Intraocular Lymphoma 10/2016
1	Disseminated Intravascular Coagulation 04/2016
1	Liver Diseases (Liver Disease) 04/2016
1	Bacterial Infections (Bacterial Infection) 04/2016

Drug/Important Bio-Agent (IBA)

6	Imatinib Mesylate (Gleevec)FDA Link 01/2022 - 07/2004
3	EnzymesIBA 04/2022 - 01/2020
3	Methotrexate (Mexate)FDA LinkGeneric 09/2019 - 10/2016
2	Fatty Acids (Saturated Fatty Acids)IBA 04/2022 - 01/2020
2	nilotinib FDA Link 01/2022 - 12/2016
2	Phospholipid Hydroperoxide Glutathione PeroxidaseIBA 01/2021 - 01/2018
2	Proteins (Proteins, Gene)FDA Link 01/2020 - 07/2017
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2019 - 01/2017
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2017 - 10/2016
2	Rituximab (Mabthera)FDA Link 01/2017 - 02/2012
2	Phosphotransferases (Kinase)IBA 03/2005 - 07/2004
1	Coenzyme A (CoA)IBA 04/2022
1	Oxidoreductases (Dehydrogenase)IBA 04/2022
1	Letrozole (Femara)FDA LinkGeneric 01/2022
1	Fulvestrant (Faslodex)FDA Link 01/2022
1	Estrogen ReceptorsIBA 01/2022
1	palbociclibIBA 01/2022
1	Methylprednisolone FDA LinkGeneric 11/2021
1	tocilizumab (atlizumab)FDA Link 11/2021
1	tisagenlecleucelIBA 11/2021
1	Ferritins (Ferritin)IBA 06/2021
1	Phospholipids (Phosphatides)FDA LinkGeneric 01/2021
1	Selenoproteins (Selenoprotein)IBA 01/2021
1	Immunoconjugates (Immunoconjugate)IBA 01/2021
1	polaprezinc (Z 103)IBA 01/2020
1	pembrolizumabIBA 01/2020
1	CopperIBA 01/2020
1	ZincIBA 01/2020
1	Hepatitis B Vaccines (Hepatitis B Vaccine)IBA 01/2020
1	Interleukin-2 Receptors (IL 2 Receptor)IBA 09/2019
1	Acetates (Acetic Acid Esters)FDA Link 04/2019
1	Bortezomib (Velcade)FDA Link 01/2019
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2019
1	Desmoglein 1IBA 01/2019
1	AntibodiesIBA 01/2019
1	Tacrolimus (Prograf)FDA LinkGeneric 01/2019
1	methylamphotericin B (AME)IBA 07/2017
1	Core Binding Factor Alpha 2 SubunitIBA 07/2017
1	Prednisone (Sone)FDA LinkGeneric 01/2017
1	Vincristine (Oncovin)FDA LinkGeneric 01/2017
1	Lenalidomide (CC 5013)FDA Link 06/2016
1	Dacarbazine (DIC)FDA LinkGeneric 04/2016

Therapy/Procedure

20	Therapeutics 04/2022 - 09/2004
3	Hematopoietic Stem Cell Transplantation 01/2022 - 09/2008
2	Stem Cell Transplantation 12/2019 - 01/2019
2	Drug Therapy (Chemotherapy) 07/2017 - 05/2009
1	Laparoscopic Cholecystectomy 01/2022
1	Intravenous Anesthesia 01/2022
1	Renal Dialysis (Hemodialysis) 01/2020
1	Salvage Therapy 12/2019
1	Radiotherapy 07/2017
1	Combination Drug Therapy (Combination Chemotherapy) 10/2016
1	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 06/2016